Dráulio de Araujo
Professor Titular; neuroscientist
Data updated
Research Footprint
Dráulio de Araujo appears in 13 tracked papers (2011–2026), most studied alongside Ayahuasca, LSD and MDMA, across Depressive Disorders, Neuroimaging & Brain Measures and Major Depressive Disorder (MDD).
Most-cited paper: Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report (483 citations).
Frequent co-authors: Draulio Araújo, Fernanda Palhano-Fontes and Jamie Hallak.
Publication Landscape
How the 13 papers Blossom tracks for Dráulio de Araujo line up by year, topic, and journal. These are the psychedelic-relevant papers in Blossom's records as of July 2026, not a complete bibliography.
How has Dráulio de Araujo's publishing grown?
SourcedTracked papers by publication year; 1 earlier paper published before 2012. Click a year for the running total.
Don't read as total output: only the 13 of 13 tracked papers with a recorded publication date are counted, and these are the psychedelic-relevant papers Blossom tracks, not a complete bibliography. The current year is still filling in.
What does Dráulio de Araujo publish on?
SourcedTracked papers per topic. Orange marks the largest research focus.
Don't read shares as adding to 100%: a paper tagged with several topics counts once per topic. These are the psychedelic-relevant papers Blossom tracks, not a complete bibliography.
Where does Dráulio de Araujo publish?
SourcedTracked papers per journal. Orange marks the most-used journal.
Counts the journal recorded on each tracked paper; preprints and papers with no journal on file are not shown. These are the psychedelic-relevant papers Blossom tracks, not a complete bibliography.
Background & Research
Dráulio Barros de Araújo earned degrees in Physics, completed a PhD in Applied Physics to Medicine and Biology, and later became a professor at the Instituto do Cérebro at the Federal University of Rio Grande do Norte (UFRN). His research focuses on neuroimaging, EEG/fMRI, altered states of consciousness induced by psychedelics, and their potential antidepressant effects. He is widely published in psychedelic science and has been involved in clinical trials of ayahuasca for depression.
Key Impact
He is a leading Brazilian neuroscientist whose work has helped shape modern clinical and neuroimaging research on ayahuasca and psychedelic antidepressant effects.
Collaboration Network
26 collaborators· click a node to visit their profile
Full network →Collaboration Network
See Dráulio de Araujo's full collaboration network, shared papers, and research connections.
Compounds
Topics
Top Collaborators
Top Collaborators
Unlock clinical summaries, full texts, and related trial mapping.